Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Elevated plasma glucose leads to pancreatic β cell dysfunction and death in type 2 diabetes. Glycogen accumulation, due to impaired metabolism, contributes to this "glucotoxicity" via dysregulated biochemical pathways promoting β cell dysfunction. Here, we review emerging data, and re-examine published findings, on the role of glycogen in β cells in normoglycemia and in diabetes.

Original publication

DOI

10.1016/j.cmet.2017.05.014

Type

Journal article

Journal

Cell Metab

Publication Date

05/07/2017

Volume

26

Pages

17 - 23

Keywords

diabetes, glycogen, insulin, pancreatic β cell, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Glycogen, Glycogen Storage Disease, Humans, Insulin-Secreting Cells, Signal Transduction